Advertisement

Topics

Preparing for ICH-GCP E6(R2) at Investigator Sites, New Xtalks Webinar Presented by Intralinks

19:00 EST 21 Feb 2017 | Marketwired

TORONTO, ON--(Marketwired - February 22, 2017) - The revised Good Clinical Practice (GCP) guideline from the International Conference on Harmonisation (ICH), known as ICH-GCP E6(R2), has now been approved. This first update in two decades is expected to be adopted worldwide by regulatory agencies, including the FDA, EMA and Japanese Health Authority, and so brings major implications for all clinical development stakeholders.

ICH-GCP E6(R2) reflects the industry's growing emphasis on risk-based quality management, highlighting the increasing complexity of clinical trials and how the ongoing evolution in technology creates opportunity for greater efficiency in quality management - specifically describing quality management as multi-faceted, with an emphasis on re-imagining protocol design to minimize complexity, unnecessary procedures and related data collection key to better decision making.

This one hour webinar follows on from the successful December 2016 session on 'Remote Monitoring and Preparing for ICH-GCP E6(R2) at Investigator Sites' (archive recording available here), which detailed and discussed what was changing from the perspective of an investigator site. Many participants requested an additional session to address further questions they now have as they prepare for future GCP audits and inspections conducted in accordance with these revised guidelines so this webinar will address pre-submitted questions.

Intralinks is also thrilled to welcome Gunnar Danielsson and his viewpoint as a retired GCP Inspector. For over a decade, Gunnar conducted countless inspections on behalf of the Swedish Medicines Agency and the European Medicines Agency (EMA). He was an active member of EMA GCP Inspectors Working Group where he had direct involvement in the development of a variety of guidelines and reflection papers.

For more information or to register for this free webinar visit: ICH-GCP E6(R2) - Live Q&A with GCP Inspector and Investigator Site Perspectives.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/2/22/11G131084/Images/Intralinks_CMYK_v1-d3182b6959a3b4afb93632a859f42aff.jpg

Contact:Dian RazakTel: +1 (416) 977-6555 ext 352Email: NEXT ARTICLE

More From BioPortfolio on "Preparing for ICH-GCP E6(R2) at Investigator Sites, New Xtalks Webinar Presented by Intralinks"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...